We are proud to present Bob S. Carter, MD, PhD, as one of our 2020 Honored Guests.
Dr. Carter is the Chair of the Department of Neurosurgery at Mass General and the William and Elizabeth Sweet Professor of Neurosurgery at Harvard Medical School. Dr. Carter is also co-founder of Mass General Neuroscience, a unique collaborative of over 2,000 faculty and clinical and research staff at MGH. One of the nation’s leading clinical neurosurgeons, Dr. Carter co-leads Massachusetts General Hospital’s brain tumor program, which is focused on brain tumor clinical care, research, and education.
As a prolific researcher, Dr. Carter's scientific work has included the development of EGFRvIII directed CAR T-cell therapy, the first characterizations of exosomes in glioblastoma, and the clinical development of novel iPS derived stem cell therapy for neurologic disorders. He has served as a principal investigator participating in the NIH-funded Extracellular RNA Communication Consortium and the NCI Liquid Biopsy Consortium. Dr. Carter leads a team of clinician scientists who have developed the role of “big data” in characterizing outcomes in oncologic and vascular neurosurgery.
Dr. Carter is extensively published, and he lectures internationally on neurosurgery topics. He has co-chaired the editorial board for the Journal of Neurosurgery and served as editorial advisory board member for Neurosurgery. Dr. Carter is known for his interest in professional mentorship, and career development of resident and faculty colleagues, including several faculty who have gone on to serve as current Chairs of Departments of Neurosurgery.
Prior to joining Mass General, Dr. Carter served as Professor and Chair of Neurosurgery at the UC San Diego School of Medicine. He earned his MD and PhD degrees at Johns Hopkins University and his BA degree in Chemistry at Brigham Young University.
Consistently elected to America's Top Doctors®, Dr. Carter is an active member of the Congress of Neurological Surgeons, the American Academy of Neurological Surgery, and the Society for Neurological Surgeons, as well as a fellow of the American Association of Neurological Surgeons. He has served on the program committee for the American Stroke Association’s International Stroke Conference and has served on the executive boards of the Joint Cerebrovascular Section and the New England Neurosurgical Society.